Cite
HARVARD Citation
Wring, S. et al. (2018). Lack of Impact by SCY‐078, a First‐in‐Class Oral Fungicidal Glucan Synthase Inhibitor, on the Pharmacokinetics of Rosiglitazone, a Substrate for CYP450 2C8, Supports the Low Risk for Clinically Relevant Metabolic Drug‐Drug Interactions. Journal of clinical pharmacology. pp. 1305-1313. [Online].